-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Health Equity Research
- Health Preference Research
- Medical Devices and Diagnostics
- Medication Adherence and Persistence
- Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II
- Joint HTAi - ISPOR Deliberative Processes for HTA
- Machine Learning Methods in HEOR
- Measurement Comparability Between Modes of Administration of PROMs
- Performance Outcome (PerfO) Assessments
- Quantitative Benefit-Risk Assessment
- Using Patient Preferences to Inform Decision Making
- Joint ISPE-ISPOR Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
Student and New Professional Members Have Access to FormularyDecisions.com!
ISPOR student and new professional members have free access to a great benefit – Dymaxium's FormularyDecisions.com®.
FormularyDecisions.com payer
ecosystem is a centralized, secure, web-based platform connecting
current and future healthcare decision makers with evidence from
leading scientific sources, insights from health technology assessment and other authoritative
reviews, and tools to evaluate new products. The platform allows users
to efficiently access, evaluate, and compare products and helps support
informed, evidence-based decisions.
For more information and to gain access, student and new professional members need to login to their ISPOR member profile.
® Dymaxium and FormularyDecisions.com are registered trademarks of Dymaxium Inc.